Symbols

HTFL

Heartflow·NASDAQ

--(--)

HTFL fundamentals

HTFL Q4 2025 Earnings

Heartflow (HTFL) released its earnings on Mar 18, 2026: revenue was 49.13M (YoY --), beat estimates; EPS was -0.12 (YoY --), beat estimates.

Revenue / YoY

49.13M

EPS / YoY

-0.12

Report date

Mar 18, 2026

HTFL Earnings Call Summary for Q4,2025

Record Growth: Q4 2025 revenue up 40% YoY to $49.1 million, with 53% global case growth and 80% non-GAAP gross margin.
Plaque Momentum: 2026 plaque revenue guidance of $15-17 million, with 1,000+ accounts targeted by year-end. Autonomous Processing to drive 85%+ gross margin by mid-term.
Innovation Pipeline: PCI Navigator launch in April 2026, with potential to expand FFRct utilization among interventional cardiologists.
Clinical Evidence: 95% IVUS agreement for Plaque Analysis; 1-year DECIDE registry outcomes to be reported mid-2026.
Competitive Advantage: Largest proprietary CT database (160M+ images), FDA clearance, and 600+ peer-reviewed publications.

Earnings

EPS

Revenue

Revenue & Expenses

HTFL has released its 2025 Q4 earnings report, with revenue of 49.13M, reflecting a YoY change of 40.46%, and net profit of -24.39M, showing a YoY change of 26.02%. The Sankey diagram below clearly presents HTFL's revenue sources and cost distribution.

Key Indicators

Heartflow (HTFL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Heartflow (HTFL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Heartflow (HTFL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Heartflow (HTFL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown